What is the purpose of the trial?

Currently, there are no specific licensed or approved drugs for the disease; and with the number of confirmed cases of COVID-19 infection arising from the SARS-CoV-2 coronavirus expected to rise substantially and rapidly, this has the potential to overwhelm the ability of the National Health Service (NHS) to cope with the increased demand.